25 research outputs found
Mortality in relation to smoking: the British Doctors Study
The British doctors study: the first strong statistical proof of association between smoking and many diseases
Potential effects of E-cigarettes and vaping in pediatric asthma
Asthma is the most common chronic disease in childhood and exposure to tobacco smoke has been long recognized as a risk factor for its onset as well as for exacerbations and poor disease control. Since the early 2000s, electronic cigarettes have been marketed worldwide as a non-harmful electronic alternative to combustible cigarettes and as a device likely to help stop smoking, and their use is continuously rising, particularly among adolescents. However, several studies have shown that vape contains many different well-known toxicants, causing significant cytotoxic and pro-inflammatory effects on the airways in-vitro and in animal models. In humans, a variety of harmful lung effects related to vaping, ranging from bronchoconstriction to severe respiratory distress has been already reported
Le nuove minacce per la salute respiratoria: il fumo elettronico
Il fenomeno dello svapo si sta diffondendo moltissimo soprattutto tra i giovanissimi. Il Pediatra Pneumologo riveste un ruolo cruciale per tentare di invertire questa tendenza, avendo un duplice compito: prevenire il tabagismo, educando i propri pazienti sui rischi e le conseguenze del fumo, e individuare i pazienti che giĂ fumano o che sono esposti a fumo, per fornire aiuto e supporto nel trattamento della dipendenza
Does lung microbiome play a causal or casual role in asthma?
Asthma is the most common chronic disease in childhood. The pathogenesis of asthma is multifactorial and is thought to include environmental factors interacting with genetics during pregnancy and in the first years of life. In the last decades, a possible role of gut microbiota in allergic disease pathogenesis has been demonstrated. Next generation sequencing techniques have allowed the identification of a distinct microbiome in the healthy lungs. The lung microbiome is characterized by the prevalence of bacteria belonging to the phylum Bacteroidetes (mostly Prevotella and Veilonella spp) in healthy subjects and to the phylum Proteobacteria in asthmatics (mostly Haemophilus, Moraxella, and Neisseria spp). In asthma, as well as in other diseases, the lung microbiome composition changes due to a disruption of the delicate balance between immigration and elimination of bacteria. The lung microbiome can interact with the immune system, thus influencing inflammation. Early infections with viruses, such as respiratory syncytial virus, may alter lung microbiome composition favoring the emergence of Proteobacteria, a phylum which is also linked to severity of asthma and bronchial hyperreactivity. Lastly, antibiotics may alter the gut and lung microbiota and potentially disturb the relationship between microbiota and host. Therefore, antibiotics should be prescribed with increasing awareness of their potential harmful effect on the microbiota in young children with and without asthma. The potential effects of probiotics and prebiotics on lung microbiome are unknown.info:eu-repo/semantics/publishedVersio
La diffusione alveolo-capillare in etĂ pediatrica
Con il termine “diffusione” si descrive il passaggio in direzioni opposte dei gas respiratori, essenzialmente l’ossigeno (O2) e l’anidride carbonica (CO2), attraverso la membrana alveolo-capillare. Il test di diffusione con monossido di carbonio (CO) utilizzando la tecnica del respiro singolo è largamente usato per la sua natura non invasiva e la rapidità con la quale le manovre possono essere ripetute. Oltre a questa tecnica, esistono numerose altre metodiche di misurazione ma, per la loro complessità , difficilmente sono utilizzabili in età pediatrica. Tutti i metodi sono molto approssimativi, risentendo delle asimmetrie del rapporto ventilazione/perfusione e delle tensioni di CO nelle differenti porzioni del polmone e suggeriscono, quindi, di limitare lo studio della diffusione della membrana alveolo-capillare ai casi nei quali possa essere realmente utile. Sono da considerare, tra questi, i soggetti in cui si sospetti una fibrosi polmonare o la presenza di processi infiammatori interstiziali, ma anche i pazienti affetti da malattie polmonari ostruttive, sia acute che croniche, e da enfisema. Infine, il test può trovare indicazione nell’asma bronchiale, dove una riduzione della capacità di diffusione è attesa solo se si verificano significative alterazioni del rapporto ventilazione/perfusione ed appare pertanto strettamente correlata all’entità dell’ostruzione bronchiale
Application of exhaled nitric oxide (FeNO) in pediatric asthma
PURPOSE OF REVIEW: Fractional concentration of Nitric Oxide in the exhaled air (FeNO) is a moderately good biomarker of type-2 airway inflammation, and its measurement is feasible also in children. The available evidence is still not enough to support the routine use of FeNO to diagnose or manage asthma in every patient in clinical practice. However, its role in identifying asthma with eosinophilic inflammation is of particular interest in the management of severe asthma.RECENT FINDINGS: In healthy subjects, FeNO levels increase with age and height, particularly in males, and are also influenced by ethnicity. FeNO measurement can support asthma diagnosis and help in predicting asthma development later in life in young children with recurrent wheezing. FeNO-guided asthma management is effective in reducing asthma exacerbations but may result in a higher daily dose of inhaled corticosteroids. FeNO can also be used as a marker to evaluate adherence to asthma treatment and predict response to different biologicals, especially Omalizumab and Dupilumab.SUMMARY: This review outlines recent data on the application of FeNO in childhood-onset asthma diagnosis and management, as well as in phenotyping subjects with severe asthma who may benefit from monoclonal antibodies administration
Chronic respiratory diseases other than asthma in children: the COVID-19 tsunami
Coronavirus disease 2019 (COVID-19) affects all components of the respiratory system, including the neuromuscular breathing apparatus, conducting and respiratory airways, pulmonary vascular endothelium, and pulmonary blood flow. In contrast to other respiratory viruses, children have less severe symptoms when infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). A minority of children experience a post-infectious inflammatory syndrome, the pathology and long-term outcomes of which are poorly understood. The reason for the lower burden of symptomatic disease in children is not yet clear, but several pathophysiological characteristics are postulated. The SARS-CoV-2 pandemic has brought distinct challenges to the care of children globally. Proper recommendations have been proposed for a range of non-asthmatic respiratory disorders in children, including primary ciliary dyskinesia and cystic fibrosis. These recommendations involve the continuation of the treatment during this period and ways to maintain stability. School closures, loss of follow-up visit attendance, and loss of other protective systems for children are the indirect outcomes of measures to mitigate the COVID-19 pandemic. Moreover, COVID-19 has reshaped the delivery of respiratory care in children, with non-urgent and elective procedures being postponed, and distancing imperatives have led to rapid scaling of telemedicine. The pandemic has seen an unprecedented reorientation in clinical trial research towards COVID-19 and a disruption in other trials worldwide, which will have long-lasting effects on medical science. In this narrative review, we sought to outline the most recent findings on the direct and indirect effects of SARS-CoV-2 pandemic on pediatric respiratory chronic diseases other than asthma, by critically revising the most recent literature on the subject
Structural and functional development in airways throughout childhood: Children are not small adults
Children are not small adults and this fact is particularly true when we consider the respiratory tract. The anatomic peculiarities of the upper airway make infants preferential nasal breathers between 2 and 6 months of life. The pediatric larynx has a more complex shape than previously believed, with the narrowest point located anatomically at the subglottic level and functionally at the cricoid cartilage. Alveolarization of the distal airways starts conventionally at 36-37 weeks of gestation, but occurs mainly after birth, continuing until adolescence. The pediatric chest wall has unique features that are particularly pronounced in infants. Neonates, infants, and toddlers have a higher metabolic rate, and consequently, their oxygen consumption at rest is more than double that of adults. The main anatomical and functional differences between pediatric and adult airways contribute to the understanding of various respiratory symptoms and disease conditions in childhood. Knowing the peculiarities of pediatric airways is helpful in the prevention, management, and treatment of acute and chronic diseases of the respiratory tract. Developmental modifications in the structure of the respiratory tract, in addition to immunological and neurological maturation, should be taken into consideration during childhood